Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.71 |
| ▸ | MAPT | P10636 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 1/20 | 0.71 |
| ▸ | TSHR | P16473 | 1/20 | 0.71 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.71 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.67 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.67 |
| ▸ | PKM | P14618 | 2/20 | 0.66 |
| ▸ | AKT1 | P31749 | 1/20 | 0.62 |
| ▸ | ATM | Q13315 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.58 |
| ▸ | CA2 | P00918 | 2/20 | 0.58 |
| ▸ | CA5A | P35218 | 2/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 1/20 | 0.58 |
| ▸ | CA3 | P07451 | 1/20 | 0.58 |
| ▸ | CA6 | P23280 | 1/20 | 0.58 |
| ▸ | CA7 | P43166 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 1/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30978753 | 0.85 | MEN1 (0.75) | ALDH1A1MAPTHPGDTSHRHSD17B10 | |
| Glybuthiazol SCHEMBL282607 | 0.85 | ALDH1A1 (0.71) | ALDH1A1MAPTHPGDTSHRHSD17B10 | |
| SCHEMBL5404442 | 0.85 | ALDH1A1 (0.71) | ALDH1A1MAPTHPGDTSHRHSD17B10 | |
| SCHEMBL5394860 | 0.85 | MEN1 (0.74) | ALDH1A1MAPTHPGDTSHRHSD17B10 | |
| SCHEMBL5401782 | 0.84 | ALDH1A1 (0.65) | ALDH1A1MAPTHPGDTSHRHSD17B10 | |
| SCHEMBL30578971 | 0.83 | ALDH1A1 (1.00) | ALDH1A1MAPTHPGDTSHRHSD17B10 | |
| SCHEMBL286763 | 0.80 | ALDH1A1 (1.00) | ALDH1A1MAPTHPGDTSHRHSD17B10 | |
| SCHEMBL1094305 | 0.80 | ALDH1A1 (0.72) | ALDH1A1HPGDPKMAKT1ATM | |
| SCHEMBL5392537 | 0.78 | ALDH1A1 (1.00) | ALDH1A1MAPTHPGDHSD17B10PKM | |
| SCHEMBL15884465 | 0.78 | CA1 (0.65) | ALDH1A1PKMATMCA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2553 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022164850-A1 | COMPOUNDS TO PREVENT OR TREAT SARS-CoV-2 VARIANT INFECTION | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INCORPORATED (US) | 2022-08-04 | — | — | WO | claimed |
| US-20180118773-A1 | CRYSTALLINE FORM OF BENZYLBENZENE SGLT2 INHIBITOR | THERACOSBIO, LLC | 2018-05-03 | — | — | US | claimed |
| US-9517273-B2 | Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids | AMBRX, INC. (US) | 2016-12-13 | — | — | US | claimed |
| US-9179994-B2 | Implantable film/mesh composite | COVIDIEN LP (US) | 2015-11-10 | — | — | US | claimed |
| US-20150273075-A1 | THERAPEUTIC USES OF MODIFIED FGF-21 POLYPEPTIDES COMPRISING NON-NATURALLY OCCURRING AMINO ACIDS | AMBRX, INC. | 2015-10-01 | — | — | US | claimed |
| US-9005308-B2 | Implantable film/mesh composite for passage of tissue therebetween | COVIDIEN LP (US) | 2015-04-14 | — | — | US | claimed |
| US-20150051289-A1 | LIQUID FORMULATIONS OF HYPOGLYCAEMIC SULFONAMIDES | AMMTEK (FR) | 2015-02-19 | — | — | US | claimed |
| US-8932621-B2 | Implantable film/mesh composite | COVIDIEN LP (US) | 2015-01-13 | — | — | US | claimed |
| EP-2819679-A1 | LIQUID FORMULATIONS OF HYPOGLYCAEMIC SULPHONAMIDES | Ammtek (FR) | 2015-01-07 | — | — | EP | claimed |
| US-20140142520-A1 | IMPLANTABLE DEVICES INCLUDING A MESH AND A PIVOTABLE FILM | COVIDIEN LP (US) | 2014-05-22 | — | — | US | claimed |
| US-20030104066-A1 | Easy-to-take granules | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-06-05 | — | — | US | claimed |
| EP-1303304-A2 | PHARMACEUTICAL COMBINATIONS FOR TREATMENT AND PREVENTION OF DIABETES MELLITUS | Keri Pharma KFT (HU) | 2003-04-23 | — | — | EP | claimed |
| WO-2003007951-A1 | A SYNERGISTIC PHARMACEUTICAL COMBINATION FOR THE PREVENTION OR TREATMENT OF DIABETES | N-GENE RESEARCH LABORATORIES INC. (US) | 2003-01-30 | — | — | WO | claimed |
| EP-1269995-A1 | EASY-TO-TAKE GRANULE | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2003-01-02 | — | — | EP | claimed |
| WO-2002005795-A2 | PHARMACEUTICAL COMBINATIONS FOR TREATMENT AND PREVENTION OF DIABETES MELLITUS | Kéri Pharma Kft. (HU) | 2002-01-24 | — | — | WO | claimed |
| CN-1294519-A | Pharmaceutical composition containing a compound having an activity of promoting the absorption of an active ingredient | INPHARMA SA (CH) | 2001-05-09 | — | — | CN | claimed |
| EP-1073470-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2001-02-07 | — | — | EP | claimed |
| WO-2000048636-A1 | PHARMACEUTICAL COMPOSITIONS CONTAINING COMPOUNDS WITH ACTIVITY FOR THE ENHANCEMENT OF ABSORPTION OF ACTIVE INGREDIENTS | INPHARMA S.A. (CH) | 2000-08-24 | — | — | WO | claimed |
| US-5811547-A | Method for inducing crystalline state transition in medicinal substance | NIPPON SHINYAJU CO., LTD. (JP) | 1998-09-22 | — | — | US | claimed |
| CN-1156403-A | Highly active sulphonyl urea preparations exhibiting rapid or controlled release of the active substance, and method of producing them | BRITISH TECHNOLOGY GROUP CO LT (GB) | 1997-08-06 | — | — | CN | claimed |